PI
Amsterdam institute for Immunology and Infectious Diseases
-
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
Frerichs, K. A., Verkleij, C. P. M., Mateos, M. V., Martin, T. G., Rodriguez, C., Nooka, A., Banerjee, A., Chastain, K., Perales-Puchalt, A., Stephenson, T., Uhlar, C., Kobos, R., van der Holt, B., Kruyswijk, S., Kuipers, M. T., Groen, K., Vishwamitra, D., Skerget, S., Cortes-Selva, D., Doyle, M., & 4 others , 9 Jan 2024, In: Blood. 8, 1, p. 194-206 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Monoclonal Antibodies in the Treatment of Multiple Myeloma
van de Donk, N. W. C. J. & Zweegman, S., 2024, (E-pub ahead of print) In: Hematology/oncology clinics of North America.Research output: Contribution to journal › Review article › Academic › peer-review
-
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Mian, H., McCurdy, A., Giri, S., Grant, S., Rochwerg, B., Winks, E., Rosko, A. E., Engelhardt, M., Pawlyn, C., Cook, G., Jackson, G., Bringhen, S., Facon, T., Larocca, A., Zweegman, S. & Wildes, T. M., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 6.Research output: Contribution to journal › Article › Academic › peer-review
- All publications